TSA treatment significantly decreased the percentage and number of CD11b+Ly6C+ monocytic MDSCs in tumor tissue, whereas no significant alterations were not detected in those of CD11b+Ly6G+ neutrophilic MDSCs (Supplementary Figure 2A). The gene discussed is ITGAM; the disease is neoplasm.